Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Recommendation of “Hold” by Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received an average recommendation of “Hold” from the seven analysts that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $4.25.

ASPN has been the topic of a number of recent analyst reports. Barclays decreased their target price on shares of Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Thursday, March 5th. Roth Mkm dropped their price target on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. TD Cowen decreased their price objective on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Zacks Research upgraded shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th.

Aspen Aerogels Price Performance

NYSE ASPN opened at $3.07 on Friday. The business’s fifty day moving average is $3.40 and its 200 day moving average is $4.66. Aspen Aerogels has a fifty-two week low of $2.30 and a fifty-two week high of $9.78. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.33 and a current ratio of 3.90. The company has a market capitalization of $253.87 million, a PE ratio of -0.65 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The company had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. During the same quarter in the previous year, the company earned $0.14 EPS. The business’s quarterly revenue was down 66.4% compared to the same quarter last year. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. Sell-side analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently made changes to their positions in ASPN. Vanguard Group Inc. grew its position in shares of Aspen Aerogels by 0.5% during the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock worth $31,392,000 after purchasing an additional 22,686 shares in the last quarter. Needham Investment Management LLC lifted its holdings in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock worth $12,315,000 after purchasing an additional 912,000 shares in the last quarter. Invesco Ltd. lifted its holdings in Aspen Aerogels by 237.9% in the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after purchasing an additional 2,907,558 shares in the last quarter. State Street Corp boosted its stake in Aspen Aerogels by 28.6% in the 4th quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock worth $7,079,000 after purchasing an additional 556,833 shares during the period. Finally, Federated Hermes Inc. purchased a new stake in Aspen Aerogels during the 2nd quarter valued at approximately $10,459,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.